{"title":"Challenges facing genetic diagnostics of Huntington's disease: an update.","authors":"Larissa Arning, Carsten Saft, Huu Phuc Nguyen","doi":"10.1080/14737159.2026.2642712","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Since 1993, when a polymorphic CAG trinucleotide repeat was established as the cause of Huntington's disease (HD), fragment analysis has been the first-tier test in genetic diagnosis of HD. However, in recent years it has become increasingly clear that, in addition to the repeat length itself, sequence variations within the <i>HTT</i> repeat and elsewhere in the genome also play a crucial role in the onset and clinical presentation of the disease.</p><p><strong>Areas covered: </strong>Sequence interruptions or non-canonical repeat motifs have historically been difficult to identify, as PCR cannot distinguish an interrupted repeat tract when assessed by capillary electrophoresis. However, these non-canonical interruptions may directly affect the phenotype or result in an underestimation of the uninterrupted CAG repeat length. While next-generation sequencing (NGS) with short read lengths has revolutionized genetic diagnostics, it faces limitations in diagnosing repeat expansion diseases. The literature search methodology involved a review of relevant studies and clinical data.</p><p><strong>Expert opinion: </strong>In contrast, long-read sequencing (LRS) generates read lengths of over 10 kb and can thus overcome the limitations associated with short reads. This enables detailed investigation of repeat sequences and the identification of complex patterns of alternating sequence motifs, potentially providing additional clinically relevant information.</p>","PeriodicalId":12113,"journal":{"name":"Expert Review of Molecular Diagnostics","volume":" ","pages":"141-147"},"PeriodicalIF":4.3000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Molecular Diagnostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737159.2026.2642712","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Since 1993, when a polymorphic CAG trinucleotide repeat was established as the cause of Huntington's disease (HD), fragment analysis has been the first-tier test in genetic diagnosis of HD. However, in recent years it has become increasingly clear that, in addition to the repeat length itself, sequence variations within the HTT repeat and elsewhere in the genome also play a crucial role in the onset and clinical presentation of the disease.
Areas covered: Sequence interruptions or non-canonical repeat motifs have historically been difficult to identify, as PCR cannot distinguish an interrupted repeat tract when assessed by capillary electrophoresis. However, these non-canonical interruptions may directly affect the phenotype or result in an underestimation of the uninterrupted CAG repeat length. While next-generation sequencing (NGS) with short read lengths has revolutionized genetic diagnostics, it faces limitations in diagnosing repeat expansion diseases. The literature search methodology involved a review of relevant studies and clinical data.
Expert opinion: In contrast, long-read sequencing (LRS) generates read lengths of over 10 kb and can thus overcome the limitations associated with short reads. This enables detailed investigation of repeat sequences and the identification of complex patterns of alternating sequence motifs, potentially providing additional clinically relevant information.
期刊介绍:
Expert Review of Molecular Diagnostics (ISSN 1473-7159) publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.
Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations featuring assessments of significant, recently published articles from specialists in molecular diagnostic therapy.
Expert Review of Molecular Diagnostics provides the forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.